Medical Device Investing NeuroMetrix and GlaxoSmithKline will Collaborate to Develop and Expand Access to Quell Wearable Pain Relief Technology
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
